Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAberd Asia Inc Regulatory News (AAIF)

Share Price Information for Aberd Asia Inc (AAIF)

Share Price is delayed by 15 minutes
Get Live Data
337.00    -6.00 (-1.75%)
Bid:
336.00
Ask:
339.00
Spread: 3.00 (0.893%)
Market Cap: £480.28m
AAIF Live PriceLast checked at - London Stock Exchange

Intraday Aberd Asia Inc Share Chart

Fourth Interim Dividend

14 Jan 2026 14:11

RNS Number : 9258O
Aberdeen Asian Income Fund Limited
14 January 2026
 

Aberdeen Asian Income Fund Limited (the "Company")

Legal Entity Identifier (LEI): 549300U76MLZF5F8MN87

 

14 January 2026

 

Declaration of Fourth Interim Dividend

 

 

Highlights

 

· Dividend yield of 6.2%.

· Quarterly interim dividend of 4.46p per share.

· Share price total return of 30.0% for the year ended 31 December 2025.

 

The Board is pleased to declare a fourth quarterly interim dividend of 4.46p per share for the year ended 31 December 2025. This is the fourth dividend payment announced by the Company since the introduction of the enhanced dividend policy in January 2025, to broaden the appeal of the Company's shares to a wider range of investors and to reflect the sustained investor appetite for yield in the current interest rate environment. Taking into account the first, second and third interim dividends already paid, this amounts to a total dividend of 16.24p per share for the year ended 31 December 2025 and equates to a dividend yield of 6.2%.

 

The Board is also pleased that the Company delivered a share price total return of 30.0% for the year ended 31 December 2025, demonstrating strong capital returns in addition to the dividends paid during the year.

 

The fourth interim dividend will be paid on 20 February 2026 to shareholders on the register at the close of business on 23 January 2026. The ex-dividend date is 22 January 2026. The Company offers the option for shareholders to invest their dividend in a Dividend Reinvestment Plan ("DRIP"), which is managed by the Company's Registrar, Computershare Investor Services PLC. The deadline for elections under the DRIP is 30 January 2026.

 

Note:

The Company's dividend policy, as announced on 16 January 2025, is to set the dividend at 1.5625% per quarter of the Company's net asset value ("NAV"), equating to approximately 6.25% of NAV per annum. The dividend is calculated using the Company's NAV on the last business day of the preceding financial quarter (i.e. the end of March, June, September and December). The fourth quarterly interim dividend of 4.46p per share is based on 1.5625% of the Company's unaudited NAV of 285.53p per share as at 31 December 2025. The dividend yield of 6.2% is based on a share price of 264p on 31 December 2025.

 

 

For further information, please contact:

 

Aberdeen (Investment Manager):

Ben Heatley, Head of Closed End Fund Sales

Ben.Heatley@aberdeenplc.com

 

Maria Allen, Client Director, Closed End Funds

Maria.Allen@aberdeenplc.com

 

Peel Hunt LLP (Corporate Broker):

Luke Simpson, Huw Jeremy (Investment Banking)

Alex Howe, Richard Harris (Sales)

020 7418 8900

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVUSASRNRUAAAR
Date   Source Headline
17th Feb 202610:32 amRNSNet Asset Value(s)
16th Feb 20261:40 pmRNSGearing disclosure
16th Feb 202612:20 pmRNSNet Asset Value(s)
16th Feb 20269:40 amRNSPortfolio disclosure
13th Feb 202612:39 pmRNSNet Asset Value(s)
12th Feb 202611:01 amRNSNet Asset Value(s)
11th Feb 202612:22 pmRNSNet Asset Value(s)
10th Feb 202612:14 pmRNSNet Asset Value(s)
9th Feb 20262:44 pmRNSGearing disclosure
9th Feb 20261:16 pmRNSNet Asset Value(s)
6th Feb 202611:20 amRNSNet Asset Value(s)
5th Feb 20262:00 pmRNSMonth End Net Asset Value(s)
5th Feb 202610:46 amRNSNet Asset Value(s)
4th Feb 202611:05 amRNSNet Asset Value(s)
3rd Feb 20265:22 pmRNSHolding(s) in Company
3rd Feb 202612:45 pmRNSNet Asset Value(s)
2nd Feb 20264:11 pmRNSGearing disclosure
2nd Feb 20269:37 amRNSCompliance with Market Abuse Regulation
30th Jan 202612:19 pmRNSNet Asset Value(s)
29th Jan 202612:19 pmRNSNet Asset Value(s)
28th Jan 202611:35 amRNSNet Asset Value(s)
27th Jan 202611:46 amRNSNet Asset Value(s)
26th Jan 20262:37 pmRNSGearing disclosure
26th Jan 202612:25 pmRNSNet Asset Value(s)
23rd Jan 202612:27 pmRNSNet Asset Value(s)
22nd Jan 202611:50 amRNSNet Asset Value(s)
21st Jan 202611:57 amRNSNet Asset Value(s)
20th Jan 202612:04 pmRNSNet Asset Value(s)
19th Jan 20262:44 pmRNSGearing disclosure
19th Jan 202612:27 pmRNSNet Asset Value(s)
16th Jan 202610:44 amRNSNet Asset Value(s)
15th Jan 202611:07 amRNSNet Asset Value(s)
14th Jan 20262:11 pmRNSFourth Interim Dividend
14th Jan 202611:35 amRNSNet Asset Value(s)
13th Jan 202611:22 amRNSNet Asset Value(s)
12th Jan 20261:04 pmRNSGearing disclosure
12th Jan 202612:11 pmRNSNet Asset Value(s)
12th Jan 20269:38 amRNSPortfolio disclosure
9th Jan 202612:16 pmRNSNet Asset Value(s)
8th Jan 202611:33 amRNSNet Asset Value(s)
7th Jan 202611:40 amRNSNet Asset Value(s)
6th Jan 20265:38 pmRNSMonth End Net Asset Value(s)
6th Jan 202611:26 amRNSQuarterly disclosure
6th Jan 202611:16 amRNSNet Asset Value(s)
5th Jan 20261:07 pmRNSGearing disclosure
5th Jan 202612:29 pmRNSNet Asset Value(s)
31st Dec 202511:14 amRNSNet Asset Value(s)
30th Dec 202511:30 amRNSNet Asset Value(s)
29th Dec 202511:54 amRNSGearing disclosure
29th Dec 202511:54 amRNSGearing disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.